본문으로 건너뛰기
← 뒤로

Beyond Physical Toxicities: Identifying Psychosocial Domains Requiring Integrated Support in Breast Cancer Pharmacotherapy.

Psycho-oncology 2026 Vol.35(1) p. e70393

Sutanto H, Ashariati A, Savitri M, Hendarsih E

📝 환자 설명용 한 줄

[BACKGROUND] Cancer pharmacotherapy imposes substantial physical and psychosocial burdens that affect patients' quality of life (QoL).

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • p-value p = 0.002
  • p-value p < 0.001

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Sutanto H, Ashariati A, et al. (2026). Beyond Physical Toxicities: Identifying Psychosocial Domains Requiring Integrated Support in Breast Cancer Pharmacotherapy.. Psycho-oncology, 35(1), e70393. https://doi.org/10.1002/pon.70393
MLA Sutanto H, et al.. "Beyond Physical Toxicities: Identifying Psychosocial Domains Requiring Integrated Support in Breast Cancer Pharmacotherapy.." Psycho-oncology, vol. 35, no. 1, 2026, pp. e70393.
PMID 41579342
DOI 10.1002/pon.70393

Abstract

[BACKGROUND] Cancer pharmacotherapy imposes substantial physical and psychosocial burdens that affect patients' quality of life (QoL). While oncologic outcomes are well studied, the psychological dimensions-particularly future perspective, emotional resilience, and body image-remain underintegrated into routine care. The growing recognition of psycho-oncology highlights the need for synergistic collaboration between oncology and clinical psychology.

[AIM] To evaluate changes in QoL before and after pharmacotherapy among women with breast cancer and identify domains most vulnerable to psychological distress, thereby informing the need for integrated psycho-oncologic care.

[METHODS] This prospective study included 106 women with breast cancer undergoing pharmacotherapy. Sociodemographic and clinical characteristics were collected, including cancer stage, treatment modalities, and baseline cardiometabolic parameters. QoL was assessed pre- and post-treatment using EORTC QLQ-C30 and BR23 instruments. Paired comparisons were performed using Wilcoxon signed-rank tests, and correlations with age were analyzed using Spearman or Pearson methods as appropriate.

[RESULTS] Global health status declined significantly after pharmacotherapy (83.3 to 66.7; p = 0.002). Functional domains-including physical, role, and social functioning-also worsened, while emotional functioning improved modestly. Symptom burden increased across fatigue, nausea, pain, appetite loss, and systemic side effects (all p < 0.001). Breast-cancer-specific domains such as body image and future perspective showed minimal change but remained highly variable, indicating psychosocial vulnerability. Distress related to hair loss demonstrated a modest inverse correlation with age (r = -0.296; p = 0.003).

[CONCLUSION] Pharmacotherapy substantially reduces multiple QoL domains, highlighting symptom-function trade-offs and persistent psychological concerns. The patterns in emotional functioning and future perspective indicate unmet psychosocial needs. These findings underscore the imperative for integrated psycho-oncology models to enhance holistic survivorship care.

MeSH Terms

Humans; Female; Breast Neoplasms; Quality of Life; Middle Aged; Prospective Studies; Aged; Adult; Psychological Distress; Antineoplastic Agents; Fatigue; Body Image

같은 제1저자의 인용 많은 논문 (2)